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INTRODUCTION: Degenerative disc disease 
(DDD) is a consequence of alterations in the 
extracellular matrix composition of the 
intervertebral disc (IVD). Studies suggest that 
mesenchymal stem cells (MSCs) have the 
ability to arrest degeneration but not regenerate 
it. We hypothesize that this is related to the 
severity of degeneration. This study 
investigates the effect of different severity of 
degeneration on the ability of MSCs to halt or 
regenerate the IVD. 
METHODS: Disc degeneration was induced in 
9 New Zealand white rabbits at 4 consecutive 
lumbar levels by annular puncture1. The 
degeneration was allowed to progress for 1 
month (early group, n=5) or 7 months (late 
group, n=4). Autologous MSCs were then 
isolated, expanded ex vivo and labeled with 
bromo-deoxyuridine (BrdU). 1x105 MSCs were 
injected into 2 of 4 degenerated discs per rabbit. 
The other 2 levels were used as control levels 
that were either sham (induced but no further 
treatment) or injected with culture medium 
only. Serial radiographs of the spine were taken 
every 2 weeks. All rabbits were sacrificed at 16 
weeks post-injection, the discs were retrieved 
for histological and immunohistochemical 
exam-ination. Disc heights on radiographs were 
measured2. A histological grading3 was used to 
assess the severity of degeneration (Grade 0 = 
normal to Grade 5 = severe degeneration).  
RESULTS: MSCs could be detected in all 
IVDs 16 weeks post-injection. For the early 
group, there were no significant differences in 
disc height between the sham discs, the 
medium-injected discs and the cell-injected 
discs. For the late group, all discs showed loss 
of height. The loss was significantly (p<0.05) 
greater for the cell-injected discs and the 
medium-injected discs than the sham discs (? 
because of double puncture). Histological 
grading of annular degeneration revealed no 
significant differences in the early group, 
whereas for the late group, the cell-injected 
discs were significantly (p<0.05) less 
degenerated than the medium-injected discs and 
sham discs (Table 1). This finding was further 
supported by histological confirmation of a near 
normal proteoglycan level within the posterior 
annulus fibrosus of the cell-injected discs 
(Figure 1). 
DISCUSSION & CONCLUSIONS: Contrary 
to intuitive belief, MSCs injection has a more 
significant effect when introduced into more 
severely degenerated discs. Although evidence 
of halting progression of degeneration can be 
demonstrated, they do not have the ability to 
regenerate the disc fully or restore disc space 
height. It is not possible to conclude from the 
current study whether this failure to regenerate 
the disc is a problem of the model itself, an 
insufficient number of cells, a lack of a scaffold 
material, or that MSCs lack this ability. Further 
studies will be needed to ascertain the stage of 
disc degeneration that would benefit most from 
stem cell-based therapy. 
 
Disc treatments Early group Late group 
Sham 
Medium-injected 
Cell-injected  
2.8 
2.5 
2.4 
4.5 
3.8 
2.1 
Table 1. Mean degenerative grades for IVDs 
subjected to different treatments. 
 
 
Fig 1. Cells-injected discs (A) restored the 
proteoglycan level (stained blue)4 when 
compared to  sham discs (B) in the late group. 
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